Agomab

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Morphic Therapeutic

This biopharmaceutical company develops oral integrin therapies for patients with serious chronic diseases, including autoimmune conditions, fibrosis, and inflammatory bowel disease.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.